Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immune Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002437
What this trial is testing

The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Gilead Sciences 48
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Not applicableStudy completedNCT00028366
What this trial is testing

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00001118
What this trial is testing

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Not Yet RecruitingNCT07540351
What this trial is testing

Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome

Who this might be right for
Allergic Rhinitis With Asthma
Beijing Daxing District Hospital of Integrated Chinese and Western Medicine 188
Not applicableStudy completedNCT00000731
What this trial is testing

Evaluation of the Interaction Between Acetaminophen and Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00000717
What this trial is testing

The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Ended earlyNCT02386098
What this trial is testing

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

Who this might be right for
HIV Infections
ViiV Healthcare 86
Not applicableStudy completedNCT00091936
What this trial is testing

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 592
Not applicableStudy completedNCT00001826
What this trial is testing

Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00000826
What this trial is testing

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Who this might be right for
Bacterial InfectionsMycosesHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00002416
What this trial is testing

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 390
Testing effectiveness (Phase 2)Study completedNCT00002233
What this trial is testing

A Combination of Four Drugs in Patients With Recent HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 30
Testing effectiveness (Phase 2)Ended earlyNCT02357147
What this trial is testing

Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Morphotek 124
Not applicableStudy completedNCT00002108
What this trial is testing

3TC (Lamivudine; GR109714X) Open-Label Program

Who this might be right for
HIV Infections
Glaxo Wellcome
Post-approval studies (Phase 4)Study completedNCT00570440
What this trial is testing

Continuous Use of COCs

Who this might be right for
Pregnancy Prevention
FHI 360 362
Large-scale testing (Phase 3)Study completedNCT00144183
What this trial is testing

Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)

Who this might be right for
Acquired Immunodeficiency Syndrome
Boehringer Ingelheim 407
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Testing effectiveness (Phase 2)UnknownNCT03315078
What this trial is testing

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

Who this might be right for
X-Linked Combined Immunodeficiency Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 13
Next Page